Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Andreas Karas"'
Autor:
Dorota Jamrozy, Francesc Coll, Alison E. Mather, Simon R. Harris, Ewan M. Harrison, Alasdair MacGowan, Andreas Karas, Tony Elston, M. Estée Török, Julian Parkhill, Sharon J. Peacock
Publikováno v:
BMC Genomics, Vol 18, Iss 1, Pp 1-12 (2017)
Abstract Background Horizontal transfer of mobile genetic elements (MGEs) that carry virulence and antimicrobial resistance genes mediates the evolution of methicillin-resistant Staphylococcus aureus, and the emergence of new MRSA clones. Most MRSA l
Externí odkaz:
https://doaj.org/article/5b2aac574e9a491191f3949061df2b9e
Autor:
Christopher M Longshaw, Anne Santerre Henriksen, Christine Slover, Yoshinori Yamano, J Andreas Karas
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:2895-2896
Autor:
Andrew Sharp, Pia Thommes, Andreas Karas, Abdul Sattar, Nasrullah Undre, Jose Alejandro Palacios-Fabrega, Peter Warn
Publikováno v:
Journal of Antimicrobial Chemotherapy. 75:2919-2924
BackgroundDuring antifungal prophylaxis, micafungin is generally infused IV once daily over 1 h. In practice, less-frequent dosing could improve the quality of life in patients requiring long-term treatment or prophylaxis. The feasibility of this app
Autor:
Benoit Guery, Andreas Karas, Areti Georgopali, Oliver A. Cornely, Gbenga Kazeem, Ingrid Michon, Mark H. Wilcox
Publikováno v:
Journal of Antimicrobial Chemotherapy. 75:1014-1018
Background Fidaxomicin is a recommended treatment for Clostridioides difficile infection (CDI) and reduces CDI recurrence incidence versus vancomycin. An extended-pulsed fidaxomicin (EPFX) regimen further reduces recurrence frequency. However, the ph
Autor:
Andreas Karas, Areti Georgopali, Maria J G T Vehreschild, Oliver A. Cornely, Gbenga Kazeem, Nicholas Adomakoh, Benoit Guery
Publikováno v:
European journal of clinical microbiology & infectious diseases, vol. 38, no. 6, pp. 1187-1194
European Journal of Clinical Microbiology & Infectious Diseases
European Journal of Clinical Microbiology & Infectious Diseases
Poor outcomes following Clostridium difficile infection (CDI) have been associated with advanced age, presence of cancer and C. difficile PCR-ribotype 027. The impact of baseline risk factors on clinical outcomes was evaluated using data from the EXT
Publikováno v:
Infectious Disease Reports, Vol 5, Iss 1, Pp e4-e4 (2013)
Pseudomonas aeruginosa bacteraemia is associated with significant morbidity and mortality. We retrospectively studied the epidemiology of bacteraemia due to P. aeruginosa in two UK district hospitals so as to determine prevention strategies and asses
Externí odkaz:
https://doaj.org/article/256ac87b0f0847f19a456b604d8c71dc
Autor:
Roger Echols, Tsutae Den Nagata, Andrew Koren, Christopher Longshaw, Yoshinori Yamano, Matteo Bassetti, Andreas Karas
Publikováno v:
The Lancet Infectious Diseases. 21:908-909
Publikováno v:
Clinical Drug Investigation
Cefiderocol (Fetroja®) is a siderophore cephalosporin and has demonstrated potent activity against extended-spectrum beta-lactamases producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and nonfermenting Gram-negative bacilli, incl
Autor:
Areti Georgopali, David A Enoch, Daniel Dedman, Tarita Murray-Thomas, Nick A Francis, Andreas Karas, Nicholas Adomakoh
Publikováno v:
The Journal of hospital infection. 106(4)
Summary Background Clostridioides difficile infection (CDI) increases the risk of complications and mortality. We assessed the magnitude of these outcomes in a large cohort of English patients with initial and recurrent CDI. Aim To compare the risk o
Publikováno v:
Infectious Disease Reports, Vol 4, Iss 1, Pp e3-e3 (2012)
Epiglottitis has been mainly associated with childhood infection with Haemophilis influenzae type B but cases of adult epiglottitis are increasing. We report here a case of adult epiglottitis and present evidence that it was caused by S. aureus. A 48
Externí odkaz:
https://doaj.org/article/277263048f54464ca7dd7285c6bac773